Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Friday, July 02, 2021 7:08:43 PM
I concur!
We are witnessing the birth of a Disruptive Bio Pharma stock similar to ENZ*C only further along with a much bigger market capacity!
Keep in mind RGBP has 20+ Patents and ENZ*C has only 1, and that's not bad by any means because it's an important Patent that holds the key to curing most strains of HIV.
RGBP on the other hand addresses a much larger playing field with its 20+ patents that are also Disruptive Biotechnology that may hold the key to curing both pancreatic & colon cancer that historically are near impossible to treat with current therapeutics.
Also RGBP is very likely a Buy Out candidate by a Big Pharma even in its early stage of development and it's 20+ Patents are a big part of that reality.
Much more could be said but I'll stop here...
LOAD & HOLD...
Be well and prosper...
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM